This study provides psychotherapy and a small dose of medication FREE OF CHARGE to eligible participants.
The goal of the study is to determine whether a small dose of an antibiotic medication called d-cycloserine can improve the effects of cognitive behavioral group therapy for social anxiety disorder.
The Therapy- Sessions take place once per week for 12 weeks, and last for 2.5 hours each
- Therapy sessions take place in groups of 4-6 people
- Cognitive behavioral therapy for social anxiety is a very effective treatment that focuses on thoughts and behaviors related to social situations. This therapy provides training in social interactions, aimed at developing skills and confidence.
The Medication
- D-cycloserine (DCS) is an antibiotic that is FDA-approved for the treatment of tuberculosis. However, some exciting new research suggests that DCS may improve learning and memory. We expect that DCS may further improve the effects of cognitive behavioral therapy by enhancing the learning process that takes place during therapy.
- Participants take DCS on 5 separate occasions. Note that participants are not asked to take the medication continuously for the 12 weeks of the study.
- DCS is administered in doses of 50mg (when DCS is used to treat tuberculosis, it is administered in doses of up to 500mg). No significant side effects are expected at this low dose.
Please call (617) 353-9229 if you are interested in participating
For additional details please see ClinicalTrials.gov